Emerging Company Showcase
The Immuno-Oncology Investing and Partnering Forum will play host to an Emerging Company Showcase as part of the program agenda. This showcase allows immuno-oncology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.
To be eligible to participate, companies must be:
- Addressing an unmet medical need
- Founded no earlier than 2013
- Actively seeking funding (startups that have raised more than $2 million in private capital or that had more than $1M in revenue in 2017 are not eligible for this showcase)
To be considered, please submit your information via the form below no later than May 25, 2018 for consideration. Entries will be reviewed by the scientific advisory board and selected companies will be notified June 1, 2018 Selected companies will receive a discounted registration rate of $500 for the Immuno-Oncology Investing and Partnering Forum.
Please note that all companies must have a valid email address and phone number to be eligible for participation in the Emerging Company Showcase. A recent news article or webpage from a investor or parent company may be submitted in lieu of a company website.